AustraliaLifestyle

Elixinol Wellness (ASX:EXL) completed the sale of its American operations to Ananda Health on Sept. 4.

SHAPE Australia (ASX:SHA) reported full-year revenue exceeding $1.2 billion for the financial year ended June 30.

Viva Leisure (ASX:VVA) posted $237.1 million in revenue and declared its first final dividend of 3 cents per share.

Cogstate (ASX:CGS) announced its financial results for the year ended June 30, delivering group revenue of US$60.9 million.

Life360 (ASX:360) increased second-quarter total revenue by 38% to US$159 million, driven by subscription and advertising growth.

The Calmer Co (ASX:CCO) executed a long-term supply agreement for noble kava with an indicative annual value of $8.7 million.

Control Bionics (ASX:CBL) has registered its NeuroStrip wearable device with the US FDA under listing number D605008.

"Data centers in space" may sound like science fiction, but as the SpaceX IPO augurs a space boom, tech giants and startups are betting orbital artificial intelligence is the next frontier.

SHAPE Australia (ASX:SHA) announced an agreement to acquire Australian Professional Shopfitters.

Viva Leisure (ASX:VVA) expects FY26 statutory NPAT to exceed $12 million, representing a growth rate of over 130%.

Life360 (ASX:360) has authorised a multi-year share repurchase programme of up to US$225 million.

Elixinol Wellness (ASX:EXL) has secured a landmark national distribution agreement with Priceline.